Varegacestat

DB13126InvestigationalSmall molecule

BMS-986115 has been used in trials studying the treatment of Various Advanced Cancer.

Chemical structure of Varegacestat
Mechanism
Curator reviewed
Formula / weight
C26H25F7N4O3 · 574.5 g/mol (avg)
Code names
AL102 · BMS-986115

Resolves to

Compound
UNIILSK1L593UUCAS1584647-27-7ChEMBLCHEMBL3911164ChEBI755976PubChem73388393
Structure
InChIKeySRJNRAQUSAVENA-GSHUGGBRSA-NSMILESCC1=CC=CC2=C1NC(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(N)=O)N=C2C1=CC=CC(F)=C1
Targets
P49768PSEN1

What you can answer from here — as of October 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Varegacestat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In